Indication
Posttraumatic Stress Disorder (PTSD)
6 registered trials testing MDMA, Ketamine, DMT for this indication, 1 recruiting now.
6
Registered trials
1
Recruiting
1
In Phase 3
Substances tested
Being studied with
Stay told
When a new trial opens
Trials
All 6 trials for Posttraumatic Stress Disorder (PTSD)
| Trial | Status | Phase | Substance | Sites |
|---|---|---|---|---|
| Ayahuasca, Esketamine and PTSDNCT07317206 · University of Sao Paulo | Recruiting | Phase 2 | ketamine, dmt | 1 |
| Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD)NCT02397889 · Icahn School of Medicine at Mount Sinai | Completed | Phase 2 / Phase 3 | ketamine | 1 |
| MDMA-AT for PTSD in Young Adults With Childhood TraumaNCT07765693 · Jenna M. Traynor | Not yet recruiting | Phase 2 | mdma | 1 |
| High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSDNCT06954025 · ARQ National Psychotrauma Centre | Enrolling by invitation | Phase 2 | mdma | 1 |
| Randomized, Double-blind, Placebo-Controlled Pilot Study of MDMA-assisted Therapy for PTSDNCT01689740 · Resilient Pharmaceuticals | Completed | Phase 2 | mdma | 1 |
| Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSDNCT07009158 · Queen's University | Not yet recruiting | Phase 1 / Phase 2 | ketamine | — |
Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.